RYTMRhythm Pharmaceuticals, Inc.

RYTM Stock Price, Valuation & Chart | Rhythm Pharmaceuticals, Inc.

Compare

$104.74-1.39 (-1.31%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology RYTM intrinsic value RYTM calculated fair value vs price

Overview Financials Dividends Ratios

RYTM Historical price chart

RYTM Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization7.18B

PE Ratio-33.68

EPS-3.11

Trading Volume322.69K

Today's High/Low108.43/104.08

Dividend Yield0.00

52 Week High/Low122.2/74.5

Shares Outstanding68.59M

RYTM Financial Statement

RYTM Analyst ratings

RYTM Analysis & performance metrics

RYTM Company profile

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic…

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin…

RYTM Management team

Name

Position

David P. Meeker M.D.CEO

Chairman, President & Chief Executive Officer

Sarah Ryan

Vice President of Sales & Marketing

Jennifer Lee

Executive Vice President & Head of North America

Alastair Garfield Ph.D.

Chief Scientific Officer

Joseph Shulman

Chief Technical Officer

Christopher P. German

Corporate Controller & Principal Accounting Officer

David Connolly

Head of Investor Relations & Corporate Communications

Hunter C. Smith M.B.A.CFO

Chief Financial Officer & Treasurer

Name

Position

David P. Meeker M.D.CEO

Chairman, President & Chief Executive Officer

Sarah Ryan

Vice President of Sales & Marketing

Jennifer Lee

Executive Vice President & Head of North America

Alastair Garfield Ph.D.

Chief Scientific Officer

Joseph Shulman

Chief Technical Officer

Christopher P. German

Corporate Controller & Principal Accounting Officer

David Connolly

Head of Investor Relations & Corporate Communications

Hunter C. Smith M.B.A.CFO

Chief Financial Officer & Treasurer

Management Team

David P. Meeker M.D.CEO

Chairman, President & Chief Executive Officer

Sarah Ryan

Vice President of Sales & Marketing

Jennifer Lee

Executive Vice President & Head of North America

Alastair Garfield Ph.D.

Chief Scientific Officer

Joseph Shulman

Chief Technical Officer

Christopher P. German

Corporate Controller & Principal Accounting Officer

David Connolly

Head of Investor Relations & Corporate Communications

Hunter C. Smith M.B.A.CFO

Chief Financial Officer & Treasurer

Management

David P. Meeker M.D.CEO

Chairman, President & Chief Executive Officer

Sarah Ryan

Vice President of Sales & Marketing

Jennifer Lee

Executive Vice President & Head of North America

Alastair Garfield Ph.D.

Chief Scientific Officer

Joseph Shulman

Chief Technical Officer

Christopher P. German

Corporate Controller & Principal Accounting Officer

David Connolly

Head of Investor Relations & Corporate Communications

Hunter C. Smith M.B.A.CFO

Chief Financial Officer & Treasurer

Total 8 executives

RYTM Frequently asked questions

What is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Price?

Current stock price of Rhythm Pharmaceuticals, Inc. (RYTM) stock is $104.74. The stock price is -1.31% lower in the session. The intraday range can be seen from this page. Volume of Rhythm Pharmaceuticals, Inc. (RYTM) stock is 322.69K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Rhythm Pharmaceuticals, Inc. (RYTM) stock price going up or down today?

The stock price of Rhythm Pharmaceuticals, Inc. (RYTM) can change with earnings, company news, and overall market sentiment. Rhythm Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Rhythm Pharmaceuticals, Inc. stock expensive at its current price?

Whether Rhythm Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RYTM on this page is -33.68. EPS on this page is -3.11. Compare those figures with peers and growth expectations before deciding if the current Rhythm Pharmaceuticals, Inc. price is justified.

How has the stock price of Rhythm Pharmaceuticals, Inc. (RYTM) performed historically?

Historical performance for Rhythm Pharmaceuticals, Inc. (RYTM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RYTM reacted to past earnings and market events.

Should I buy Rhythm Pharmaceuticals, Inc. (RYTM) stock, at this price?

Buying Rhythm Pharmaceuticals, Inc. (RYTM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.